ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Price Alert

Rocket Pharmaceuticals In... (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

3.83

0.08 (2.13%)

At close: Aug 21, 2025, 3:27 PM

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

RCKT News

3 hours ago - RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study - zacks.com
1 day ago - Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed. - barrons.com
1 day ago - FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy - benzinga.com
1 day ago - US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial - reuters.com
1 day ago - Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease - businesswire.com
10 days ago - FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - businesswire.com
13 days ago - Deadline Soon: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - businesswire.com
14 days ago - Rocket (RCKT) Q2 Loss Narrows 16% - fool.com
19 days ago - RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - businesswire.com
27 days ago - Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours - benzinga.com

Add to Watchlist

✕

Stocknear

All-in-one Stock Analysis Platform to research your trading ideas.

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Get Support
Learning Center
Advertise

Website

Login
FAQ
Sitemap

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Imprint

© 2025 Stocknear. All rights reserved.